---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-23-000129"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T00:29:46.479153+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst beats Q3 guidance; raises FY2023 revenue outlook; Adj. EBITDA positive

## Summary
- Q3 total revenue $73.8M (+8% YoY), above guidance midpoint; net loss $22.0M vs $45.7M loss in Q3 2022.
- Adjusted EBITDA $2.0M (improvement from -$4.6M YoY), also above guidance midpoint of $1.25M.
- Raised FY2023 revenue guidance to $291M-$296M from $290.5M-$295.5M; reiterated Adj. EBITDA $10M-$12M.
- New DOS client: Accountable Health Partners (~400k patients); Q4 expected to be a large bookings quarter.
- Mid-term targets: revenue reacceleration in 2024, 10% Adj. EBITDA margin in 2025, long-term 20%+ growth.

## SEC filing metadata
- accession: 0001636422-23-000129
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/0001636422-23-000129-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/hcat-20231102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-23-000129
- JSON: https://secwatch.observer/filing/0001636422-23-000129.json
- Plain text: https://secwatch.observer/filing/0001636422-23-000129.txt

## Key facts
- Earnings Releases
  Health Catalyst, Inc. reported the quarter ended September 30, 2023 results: revenue $73.8 million, net income $(22,032) thousand. Guidance raised.
  - Period: the quarter ended September 30, 2023
  - Revenue: $73.8 million
  - Net income: $(22,032) thousand
  - Guidance: raised
  - Result: reported results
  source text: reported financial results for the quarter ended September 30, 2023. “For the third quarter of 2023, I am pleased by our strong financial results, including total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, with these results beating the mid-point of our quarterly guidance on each metric. Additionally, we are grateful to be in a position to raise
  evidence_url: https://www.sec.gov/Archives/edgar/data/1636422/000163642223000129/0001636422-23-000129-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.